Last week, Senators Schumer (D-NY), Booker (D-NJ), and Wyden (D-OR) circulated a discussion draft of the Cannabis Administration and Opportunity Act, a legislative proposal to deschedule and legalize cannabis.  In related statements to the Senate, Senator Schumer emphasized that cannabis legislation will be prioritized during this Congress, stating “it’s time to end the federal prohibition on marijuana [a]nd as majority leader, I am going to push this issue forward and make it a priority.”

While there is much to explore in the bill’s 163 pages, here are five immediate takeaways for the cannabis industry. Continue Reading Senators Propose Cannabis Descheduling Plan: Five Takeaways for The Cannabis Industry

The third version of the Marijuana Opportunity Reinvestment and Expungement, or MORE, Act was introduced on May 28. Perkins Coie lawyers Barak Cohen and Andrew Kline, in partnership with Yoko Miyashita, CEO of Leafly, authored an article discussing the bill. They make the case that Congress should regulate intentionally and make certain that state and federal regulatory authority is spelled out clearly in any cannabis descheduling bill. They also argue that a transition period is needed prior to interstate commerce or imports to ensure that we protect the public health, preserve critical social equity programs, and safeguard American jobs.

To read the article, click here.

As cannabis is legalized on a state-by-state basis, individual states are creating their own cannabis testing requirements to ensure consumer safety, and many of these requirements differ from one state to the next.  Perkins Coie associate Michael Bleicher is joined by Alena Rodriguez, Managing Director of Rm3 Labs, a leading cannabis testing laboratory in Colorado. During the podcast, Michael and Alena discuss the different testing guidelines for marijuana and hemp as well as new testing for delta-8 and delta-10. Alena also shares her thoughts on the role for state labs in a post descheduling world.

Listen to Cannabis Lab Testing and Standards Post De-Scheduling: A Conversation with Alena Rodriguez on Spreaker.

Note that all episodes are available on AppleGoogle and Spotify.

It is well known that the varying state regulations for cannabis give this industry a complex legal landscape.  Nowhere is that more apparent than in the state regulations related to cannabis packaging and labeling.  Perkins Coie senior counsel Andrew Kline is joined by Doug Fischer, General Counsel of Greenlane, the leading global platform for the development and distribution of premium cannabis accessories and lifestyle products. Throughout the podcast, Doug shares his thoughts on how descheduling could impact the cannabis industry. Doug and Andrew also touch on delta-8 and the medical community’s involvement in the industry.

Listen to Packaging and Labeling Post De-Scheduling: A Conversation with Doug Fischer on Spreaker.

Note that all episodes are available on AppleGoogle and Spotify.

Medical marijuana is playing an increasingly significant role in the quality of life for Americans, especially veterans. Perkins Coie partner Barak Cohen is joined by Nick Etten, Founder and Chairman of the Veterans Cannabis Project and Head of Government Affairs at Acreage Holdings. As veterans themselves, Barak and Nick discuss how veterans are utilizing cannabis as a way to cope with certain war-related injuries, such as post-traumatic stress and depression. Nick also shares his thoughts about current treatment options through the U.S. Department of Veterans Affairs (VA) and how the VA needs to evolve to effectively meet veterans’ healthcare needs

Listen to The Cannabis Industry for Veterans: A Conversation with Nick Etten on Spreaker.

Note that all episodes are available on AppleGoogle and Spotify.

In many real estate transactions, title insurance companies fulfill a variety of roles, from providing title reports and issuing title policies to acting as the escrow agent for the closing, any holdbacks, and construction draws. However, when it comes to transactions involving cannabis companies and/or properties that will be used for cannabis-related purposes, title companies are significantly limited in the services they offer. Continue Reading Cannabis, Real Estate & Title Companies

Today, the U.S. Federal Trade Commission (FTC) announced a settlement in its most recent law enforcement action in its ongoing efforts to monitor the marketplace regarding misleading cannabidiol (CBD) product claims. The action targets Kushly Industries LLC (Kushly) and the company’s sole officer for allegedly making false or unsupported health benefit claims about Kushly’s CBD product. Continue Reading FTC Continues Crackdown on Unsupported CBD Marketing

Perkins Coie senior counsel Andrew Kline is joined by Andrew Freedman, Colorado’s first cannabis czar under Governor Hickenlooper and current Executive Director of the Coalition for Cannabis Policy, Education, and Regulation (CPEAR). Andrew’s role in developing a successful operating model for cannabis regulation and stakeholder collaboration was identified as one of the reasons for the State of Colorado’s success in implementing adult-use cannabis legalization by the Brookings Institution. Throughout the podcast, Andrew provides his perspective on how various players in the cannabis industry would be impacted by federal legalization and why the industry needs to come together to move legalization forward.

Listen to The Big Questions Facing Federal Cannabis Legalization: A Conversation with Andrew Freedman Executive Director of the Coalition for Cannabis Policy, Education, and Regulation (CPEAR) on Spreaker

Note that all episodes are available on AppleGoogle and Spotify.

Most Americans are familiar with the term “THC” at this point. What they might not yet appreciate is that common nomenclature is actually referring to Delta-9-tetrahydrocannabinol or “Delta-9” THC. That’s the scientific terminology for the molecule in marijuana that’s well-known for its psychoactive properties—i.e., what causes a “high.” Delta-9 is a cannabinoid and there are hundreds of different cannabinoids within any given cannabis plant. Continue Reading Delta-8: A New Low in Highs

On March 3, 2021, Perkins Coie partner Barak Cohen moderated a panel to discuss the future of the cannabis industry. Panelists included Michelle Rutter Friberg, Deputy Director of Government Relations at the National Cannabis Industry Association, Steve Hawkins, Executive Director of the Marijuana Policy Project, Yoko Miyashita, Chief Executive Officer of Leafly, and Andrew Kline, Senior Counsel of Perkins Coie and former public policy director for the National Cannabis Industry Association. Our latest podcast provides a recap of the discussion related to state legalization and the private sector perspective.

Listen to The Future of Cannabis: State Legalization and Private Sector Perspective on Spreaker.

Note that all episodes are available on AppleGoogle and Spotify.